Mark A. Gardner's Insider Trades & SAST Disclosures

Mark A. Gardner's most recent trade in Quest Diagnostics, Inc. was a trade of 120 Common Stock done at an average price of $155.7 . Disclosure was reported to the exchange on Sept. 24, 2024.

Stock Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Quest Diagnostics, Inc.
Mark A. Gardner SVP of Molecular Gen & Oncol 24 Sep 2024 120 4,673 (0%) 0% 155.7 18,684 Common Stock
Quest Diagnostics, Inc.
Mark A. Gardner SVP of Molecular Gen & Oncol 28 Feb 2024 262 4,793 (0%) 0% 126.4 33,106 Common Stock
Quest Diagnostics, Inc.
Gardner A. Mark SVP of Molecular Gen & Oncol 14 Feb 2024 9,376 9,376 - - Non-Qualifed Stock Option (right to buy)
Quest Diagnostics, Inc.
A. Mark Gardner SVP of Molecular Gen & Oncol 14 Feb 2024 2,250 5,055 (0%) 0% 0 Common Stock
Quest Diagnostics, Inc.
Mark A. Gardner SVP of Molecular Gen & Oncol 25 Sep 2023 116 2,805 (0%) 0% 126.2 14,642 Common Stock
Quest Diagnostics, Inc.
Mark A. Gardner SVP of Molecular Gen & Oncol 23 Feb 2023 7,584 7,584 - - Non-Qualifed Stock Option (right to buy)
Quest Diagnostics, Inc.
Mark A. Gardner SVP of Molecular Gen & Oncol 23 Feb 2023 1,919 2,921 (0%) 0% 0 Common Stock
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades